David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap
SNAP
|
+$362M |
| 2 |
Lockheed Martin
LMT
|
+$361M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$354M |
| 4 |
Fidelity National Information Services
FIS
|
+$354M |
| 5 |
Boston Scientific
BSX
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$559M |
| 2 |
Advanced Micro Devices
AMD
|
+$558M |
| 3 |
Boeing
BA
|
+$530M |
| 4 |
Lowe's Companies
LOW
|
+$525M |
| 5 |
Alibaba
BABA
|
+$420M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.94% |
| 2 | Consumer Discretionary | 10.41% |
| 3 | Healthcare | 9.22% |
| 4 | Communication Services | 7.29% |
| 5 | Financials | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
CALL
BioMarin Pharmaceuticals
BMRN
$12.8B
| $1.75M | ﹤0.01% |
20,000
| – | – |
|
|
HES
2527
PUT
DELISTED
Hess
HES
| $1.75M | ﹤0.01% |
33,200
| – | – |
|
2528
CALL
Penumbra
PEN
$12.8B
| $1.75M | ﹤0.01% |
+10,000
| New | +$2.19M |
|
|
ADAM
2529
PUT
Adamas Trust
ADAM
$884M
| $1.75M | ﹤0.01% |
118,500
+106,000
| +848% | +$1.34M |
|
2530
CALL
Public Service Enterprise Group
PEG
$36.5B
| $1.75M | ﹤0.01% |
+30,000
| New | +$1.75M |
|
2531
Kraft Heinz
KHC
$30B
| $1.75M | ﹤0.01% |
50,403
-347,699
| -87% | -$11.3M |
|
2532
CALL
Ternium
TX
$10.8B
| $1.75M | ﹤0.01% |
+60,000
| New | +$1.48M |
|
|
BNFT
2533
DELISTED
Benefitfocus, Inc.
BNFT
| $1.73M | ﹤0.01% |
119,490
+24,313
| +26% | +$297K |
|
|
STFC
2534
DELISTED
State Auto Financial Corp
STFC
| $1.73M | ﹤0.01% |
97,508
+27,356
| +39% | +$415K |
|
2535
Solid Biosciences
SLDB
$1.06B
| $1.72M | ﹤0.01% |
15,091
-4,478
| -23% | -$283K |
|
2536
ITT
ITT
$18.4B
| $1.71M | ﹤0.01% |
22,217
-70,892
| -76% | -$4.95M |
|
|
RESI
2537
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $1.71M | ﹤0.01% |
105,382
-214,171
| -67% | -$2.97M |
|
2538
CALL
Sarepta Therapeutics
SRPT
$2B
| $1.71M | ﹤0.01% |
10,000
| – | – |
|
2539
Oaktree Specialty Lending
OCSL
$1.16B
| $1.7M | ﹤0.01% |
101,824
+13,165
| +15% | +$204K |
|
2540
RingCentral
RNG
$5.48B
| $1.7M | ﹤0.01% |
+4,485
| New | +$1.4M |
|
|
GTH
2541
DELISTED
Genetron Holdings Limited ADS
GTH
| $1.7M | ﹤0.01% |
+40,450
| New | +$1.47M |
|
2542
CALL
National Beverage
FIZZ
$3.12B
| $1.7M | ﹤0.01% |
+40,000
| New | +$1.72M |
|
2543
PUT
Synaptics
SYNA
$3.71B
| $1.7M | ﹤0.01% |
17,600
| – | – |
|
2544
PUT
Axsome Therapeutics
AXSM
$10.8B
| $1.7M | ﹤0.01% |
20,800
| – | – |
|
2545
Cadiz
CDZI
$351M
| $1.69M | ﹤0.01% |
159,067
+41,504
| +35% | +$416K |
|
2546
Rollins
ROL
$17.5B
| $1.69M | ﹤0.01% |
43,356
-525,159
| -92% | -$20.4M |
|
2547
TriNet
TNET
$3.2B
| $1.69M | ﹤0.01% |
21,010
+9,109
| +77% | +$674K |
|
2548
Marriott Vacations Worldwide
VAC
$4.02B
| $1.69M | ﹤0.01% |
12,292
-45,178
| -79% | -$5.33M |
|
2549
CALL
Trip.com Group
TCOM
$29B
| $1.69M | ﹤0.01% |
50,000
-40,000
| -44% | -$1.3M |
|
|
BERY
2550
CALL
DELISTED
Berry Global Group, Inc.
BERY
| $1.69M | ﹤0.01% |
32,670
-3,158
| -9% | -$151K |
|
Similar funds
David Shaw's Q4 2020 Portfolio in Review
As of Q4 2020, David Shaw held 4,343 positions worth $112B, up 14% from $97.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $10.3B in Q4 2020, closing 477 positions and reducing 1,508 holdings. Its most notable exit was iShares Gold Trust, an estimated $217M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Snowflake worth $147M.
- David Shaw's largest Q4 2020 buy was Snowflake: 523,721 shares worth $147M.
- David Shaw added most to Snap in Q4 2020, an estimated $362M increase.
- David Shaw's biggest Q4 2020 reduction was Tesla, cutting an estimated $559M.
- David Shaw fully exited iShares Gold Trust in Q4 2020, selling an estimated $217M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q4 2020.
- David Shaw opened 563 new positions and closed 477 in Q4 2020.
- David Shaw's portfolio value rose 14% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.